Home Companies Roche Page 3

Roche

Latest

Gene Therapy

New Spark: Successor to Build on Work of Departing CEO Jeffrey Marrazzo

Liquid Biopsies

Blood Stake: Roche Raises Freenome Investment to $360M

Mystic Blue Eye

Cell Therapy

Lineage 2.0: Cell Therapy Developer Eyes Next Phase after Genentech Collaboration for Dry AMD

Gene Therapy

Spark Therapeutics Plans $575M Philadelphia Gene Therapy Center

Network forming AI robot face

Artificial Intelligence

Roche, Genentech, Recursion Launch Up-to-$12B AI Drug Discovery Effort

Roche

FDA Approves First Non-Chemo Combination Therapy for a Form of Leukemia

Roche

Genentech to Co-Develop Immunocore Cancer Immunotherapy Candidate IMC-C103C

$Epizyme is halting a Phase II trial assessing its lead candidate tazemetostat in relapsed and/or refractory diffuse large B-cell lymphoma (pictured)$

Roche

Epizyme Halts Phase II Trial of Tazemetostat in DLBCL Cohorts, Continues...

Roche

Got Milk? Roche to Apply PureTech Exosomes Platform in $1B+ Collaboration

Roche

Genentech, Microbiotica to Develop Microbiome-Based IBD Treatments

Roche

Roche Halts Development of SMA Candidate Olesoxime

Roche

Patient Deaths Cited as Darzalex Combination Trials Halted

Roche

Genentech Terminates IDO Inhibitor Partnership with NewLink

Roche

Genentech, Lodo Therapeutics Ink Up-to-$969M Metagenomics Drug Discovery Partnership

Roche

Genentech, Kineta to Partner on Non-Opioid Pain Treatments

1 234 5 Page 3 of 5